Haleon PLC (LSE:HLN, NYSE:HLN) intends to slash hundreds of jobs in the UK and potentially thousands worldwide, according to the Guardian.
The company, which makes Sensodyne toothpaste, Centrum vitamins and Panadol painkillers, plans the widespread layoffs a year after being spun off from Britain’s second-biggest drugmaker GSK.
Haleon has 24,000 staff across 170 countries and employs 1,700 people in the UK, spread across its global headquarters and its research and development labs in Weybridge in Surrey, and a manufacturing site in Maidenhead.
The company is one of the world’s biggest consumer healthcare groups and sells over-the-counter drugs, vitamins and oral care products.
The Guardian said staff were briefed on the redundancies this week in a series of meetings, and a consultation process, which started on Wednesday, will close on 25 August.
The job cuts are part of a broader cost-cutting programme aimed at saving £300mln in the next three years.